Oncology
Providers using this tag (357)
Ranked by API Evangelist rating — Exemplar and Strong are expanded by default.
Developing 3 Usable, with meaningful gaps to close
Thin 4 Limited public surface area
Emerging 76 Early or largely undocumented
BostonGeneOncoLensConcertAIStrata OncologyPreciseDxChampions OncologyBoundless BioWaivArtiosMBrace TherapeuticsC. R. BardRefleXion MedicalAvenzo TherapeuticsElektaAtaraxisCertis OncologyFlatiron HealthSvastiaOneHealthCompanyPi HealthAnnexus HealthChromaCodeA2 BiotherapeuticsPaigeIonetixAlloplex BiotherapeuticsArtera Decisionrisk AnalysisDroplet BiosciencesNusanoRadical HealthAbcuroGSKNeomorphMOMA TherapeuticsCircle PharmaOrionis BiosciencesMemo TherapeuticsAdaptive BiotechnologiesLeal Health (fka TrialJectory)Vergent BioscienceBelharra TherapeuticsAntares TherapeuticsFlare TherapeuticsTwinStrand BiosciencesGT Medical TechnologiesInvitaeNiKang TherapeuticsWugenAccessHopeLanternsophiageneticsCaidyaUltimagenomicsBristol Myers SquibbKartos TherapeuticsKSQ TherapeuticsZetagen TherapeuticsEDDA TechnologyDeepScribeDragonfly TherapeuticsBillionToOneFidocureEnableForesight DiagnosticsOncoC4Francis MedicalMassive BioAmgenPhotys TherapeuticsComplement 1Tempus AI3T BiosciencesLEAF4LifeCooler HeadsAulosRepertoire Immune Medicines
Minimal 268 Almost no public developer surface
Kirilys TherapeuticsAlpha-9 OncologyApollomicsasieriscrownbioIdeaya BiosciencesOpna BioValar LabsAdlai NortyeAktis OncologyThyme Care4D PathMariana OncologyTriomicsAlpheus MedicalBioCyticsNextPoint TherapeuticsArtiospharmaAlterome TherapeuticsRadionetics OncologyCG OncologyCarolina BioOncology InstitutePheon TherapeuticsBugworks ResearchBonumtherapeuticsCarrick TherapeuticsClasp TherapeuticsDelphia TherapeuticsTreadwell TherapeuticsUmoja BiopharmaTrial LibraryLuminateRevolution MedicinesCerula CareAcornmedCytomX TherapeuticsMendel AIScorpion TherapeuticsSyapseBiohengBeiGeneDizal PharmaForty Seven *Gritstone OncologyHexagon Bio1yongcloudPredictive Oncology (Precision Therapeutics)CivaTech OncologyAvenzo TherapeuticsaceatherapeuticsD2G OncologyNimbus TherapeuticsOlemaPathios TherapeuticsStipple BioTenSixty BioAlphina TherapeuticsEpic SciencesOdyssey TherapeuticsBiosceptreFunction OncologyMillennium PharmaceuticalsTrillium TherapeuticsVerastemVivace TherapeuticsKymera TherapeuticsImmunitas TherapeuticsAbelZeta PharmaAdcentrx TherapeuticsDren BioEureka TherapeuticsGalvanize TherapeuticsltztherapeuticsNuProbeOnco.comOutcomes4MePeel TherapeuticsSidewinder TherapeuticsTelix PharmaceuticalsTerremoto BiosciencesThird Arc BioVividion TherapeuticsVivorCareZai LabLabGenius TherapeuticsOutpace BioOnKure TherapeuticsHotSpot TherapeuticsAdicet BioArriVentCompass TherapeuticsDay One BiopharmaceuticalsGan & Lee PharmaceuticalsTyra BiosciencesVirIambic TherapeuticsObsidian TherapeuticsBioNTechBlossomHill TherapeuticsDewpoint TherapeuticsElectra TherapeuticsFrontier MedicinesTotus Medicines4D LifetecAccent TherapeuticsantengeneAsher BiotherapeuticsAuron TherapeuticsCartography BiosciencesEvergreen TheragnosticsPAQ TherapeuticsParabilis MedicinesRezo TherapeuticsAcepodiaBicara TherapeuticsGandeevaAdvanCellARTBIOAsherbioBiosapienincCoRegenHistoSonicsADC TherapeuticsArvinasBright Peak TherapeuticsEnlaza TherapeuticsRayzeBioSolu TherapeuticsArtivaCREATE MedicinesAngiexInitial TherapeuticsRgenixPrognomiQRondo TherapeuticsPathosRakuten MedicalAspyriantherapeuticsEikonAbgenomicsCandel TherapeuticsGeneos TherapeuticsGrey Wolf TherapeuticsMestag TherapeuticsPrevetaBarinthus BiotherapeuticsNoetikStrand Therapeutics1ST BiotherapeuticsHummingbird BioscienceAI Medical ServiceConvergent TherapeuticsCANbridge PharmaceuticalsGranza BioPrimmune TherapeuticsRgenta TherapeuticsTreeline BiosciencesSynthekineAbproAdcendoLink Cell TherapiesProkariumArcus BiosciencesComplete OmicsRatio TherapeuticsAqtualBoaoxinAvistoneShennon BiotechnologiesTen63 TherapeuticsCatalYm858 TherapeuticsAuransaAutolusCure GeneticsEpiBiologicsInventisBioNueclearOrca BioIsomorphic LabsRecursion PharmaceuticalsDEM BioRelay TherapeuticsExscientiaCurocellRed RidgeBioAlpha BiopharmaCelgeneImmune-Onc TherapeuticsAbCelleraAccutar BiotechnologyAccurate InternationalAipuqiangAnkyra TherapeuticsAntiva BiosciencesAvenda HealthBioTheryXCullgenDamae MedicalDeepCellInnoventInstyllaJacobio PharmaRAPT TherapeuticsRome TherapeuticsShasqiVirtuoso TherapeuticsMonte Rosa Therapeutics *Soley TherapeuticsABM TherapeuticsAbTisAllorion TherapeuticsCTRL TherapeuticsGeorgiamuneHumane GenomicsPineTree TherapeuticsQuanta TherapeuticsSURGE TherapeuticsabbiskoaistarfishAxcelius I/IIChimerixData Driven BioscienceEpizymeGeneral ProximityIconOVir BiokechowpharmaKronos Bio *Liberate BioNested TherapeuticsPACT PharmaPersonalisPliant TherapeuticsSenti BiosciencesSinotauStylus MedicineTScan TherapeuticsGrove BiopharmaMedikineoricellOvert1200 PharmaAbdera TherapeuticsABK BiomedicalArctherapeuticsAriceumtherapeuticsSCG Cell TherapysinocelltechCargo TherapeuticsConvalifepharmaceuticalsAncora BiotechBeihaibiotechBipar Sciencesi-Incubator HealthcareKelun-BiotechManas AIMillennium PharmaNextcureNormunityTeligeneIntrepida BioSynthetic Design LabCell Design LabsCell PathwaysEQRxgammastarImmuniconShoreline Biosciences
Unrated 4 Not yet scored
APIs with this tag (4)
Ranked by the provider's API Evangelist rating — the Kin Score is scored per provider, not per API, so every API of a provider shares its band. How the rating works →
Thin 1 Limited public surface area
Emerging 3 Early or largely undocumented
Elephas Portal APIThe private backend API behind the Elephas Portal, the secure cloud-based web application through which cli...Natera OncoEMR (Flatiron) IntegrationNatera's oncology testing portfolio integrated into Flatiron Health's cloud-based OncoEMR platform for elec...Tempus OneTempus One is an AI clinical assistant giving oncology providers voice and text access to patient data, cli...
Companies reaching this through an API (2)
These companies publish an API, specification or operation carrying “Oncology” but do not classify their business under it. Listed unranked and kept out of the count above, because one tagged operation is not a statement about what a company does.
Score breakdown
Frequency
69.4
log-scaled weighted occurrences
Breadth
8.4
spread across providers
Quality lift
9.8
mean composite of providers using it
Cohesion
0.0
strength of nearest seed neighbor
Where this tag sits
357 providers carry this tag directly, and 358 counting the 2 narrower tags below — 1 more to reach.
Related tags
Biotechnology 251 co-occurrences
Pharmaceuticals 162 co-occurrences
Life Sciences 231 co-occurrences
Drug Discovery 108 co-occurrences
Precision Medicine 74 co-occurrences
Immunotherapy 53 co-occurrences
Clinical Trials 82 co-occurrences
Biopharmaceutical 41 co-occurrences
Where this tag comes from
Provider tag357
Api tag4
Markets provisional
Kin Score markets whose measured providers carry this tag. Share is the fraction of the market's measured providers that carry it — it describes the market, not this tag.
| Market | Share of the market's providers |
|---|---|
| Clinical Trial Sponsors (drug pipelines) | 24% |
| Cell & Gene Therapy | 22% |
Cohort brief
Auto-generatedThe 313 providers in the APIs.io catalog tagged Oncology, scored on the Kin Score. Every figure below is computed from the catalog — nothing here is written.
Providers
313
of 359 in the catalog
Mean Kin Score
even vs catalog
Mean Agent Readiness
2.5
-9.5 vs catalog 12
Spread
–
median · σ
How the 313 split by band
Exemplar 0Strong 1Developing 4Thin 4Emerging 78Minimal 226
Facet averages, against the whole catalog
| Facet | This cohort | Catalog | Difference | Scored |
|---|---|---|---|---|
| Contract Governance | 2 | 6.5 | -4.5 | 313 |
| Discoverability | 52.1 | 57.9 | -5.8 | 313 |
| Access Clarity | 12.7 | 23.9 | -11.2 | 313 |
| Operational Transparency | 1.7 | 13 | -11.3 | 313 |
| Contract Quality | 1.5 | 17.2 | -15.7 | 313 |
| Developer Ergonomics | 7.3 | 23.2 | -15.9 | 313 |
A facet is averaged over the members that carry it, not over the whole cohort — the “Scored” column is that count. Averaging an absent facet as zero would score our own coverage gaps as the providers’ posture.
What this cohort publishes
| Artifact | This cohort | Catalog | Difference |
|---|---|---|---|
| MCP server (any) | 3% | 13% | -10 |
| MCP server (first-party) | 1% | 12% | -11 |
| Agent Skills | 0% | 0% | 0 |
| OAuth scopes | 3% | 11% | -8 |
| Security | 99% | 98% | +1 |
| Arazzo workflows | 0% | 2% | -2 |
| Governance rules | 1% | 16% | -15 |
mcp_pct counts any mcp/ artifact including ones API Evangelist derived from the provider OpenAPI; mcp_first_party_pct counts only servers the provider publishes. Prefer the latter.
Top by Kin Score
Top by Agent Readiness
- 1 xCures {"score" => 59.5, "band" => "agent-ready"}
- 2 Aignostics {"score" => 47.2, "band" => "agent-ready"}
- 3 Color {"score" => 44.7, "band" => "agent-ready"}
- 4 A2 Biotherapeutics {"score" => 39.6, "band" => "agent-ready"}
- 5 Genialis {"score" => 36.9, "band" => "agent-ready"}
- 6 TailorMed {"score" => 34.9, "band" => "agent-ready"}
- 7 Orakl {"score" => 30.5, "band" => "agent-ready"}
- 8 Varian Medical Systems {"score" => 28.4, "band" => "agent-aware"}
- 9 Droplet Biosciences {"score" => 26.3, "band" => "agent-aware"}
- 10 Ionetix {"score" => 20.9, "band" => "agent-aware"}
All 359 members of this roster resolve to a provider in the
catalog; 313 carry a score (87%).
The figures above describe the scored members only.
Coverage caveat. 312 of 313 scored members had under half their catalog-attributable points satisfied at all (catalog_earned / catalog_max < 0.5). They are INCLUDED in the mean above. A large share here means the cohort mean is partly a measurement of how far our enrichment reached, not only of how these providers publish.Generated from the catalog build of 31 October 2026, across 31983 providers, using the same computation served by the APIs.io cohort API. Briefs are published for rosters of 5 or more scored providers; below that a distribution is not meaningful.
Coverage caveat. 312 of 313 scored members had under half their catalog-attributable points satisfied at all (catalog_earned / catalog_max < 0.5). They are INCLUDED in the mean above. A large share here means the cohort mean is partly a measurement of how far our enrichment reached, not only of how these providers publish.Generated from the catalog build of 31 October 2026, across 31983 providers, using the same computation served by the APIs.io cohort API. Briefs are published for rosters of 5 or more scored providers; below that a distribution is not meaningful.
Work with this as data
Every tag here is available over the APIs.io API and to AI agents over MCP.